高级检索
当前位置: 首页 > 详情页

miR-20a-5p contributes to osteogenic differentiation of human dental pulp stem cells by regulating BAMBI and activating the phosphorylation of Smad5 and p38.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]State Key Laboratory of Oral Diseases & National Clinical Research Center forOral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section, South Renmin Road, Chengdu 610041, Sichuan, China [2]Department of Temporomandibular Joint, West China Hospital ofStomatology, Sichuan University, Chengdu, China [3]Department ofOrthodontics, West China Hospital of Stomatology, Sichuan University,Chengdu, China [4]Department of Stomatology, Sichuan Cancer Hospital &Institute, Sichuan Cancer Center, School of Medicine, University of ElectronicScience and Technology of China, Chengdu, China
出处:
ISSN:

关键词: miR-20a-5p Human dental pulp stem cells Osteogenesis BAMBI

摘要:
Human dental pulp stem cells (hDPSCs) are the preferable choice of seed cells for craniomaxillofacial bone tissue regeneration. As a member of the miR-17-92 cluster, miR-20a-5p functions as an important regulator during bone remodeling. This study aimed to investigate the roles and mechanisms of miR-20a-5p during osteogenesis of hDPSCs.Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was conducted to determine the expression of miR-20a-5p during osteogenesis of hDPSCs. We interfered with the expression of miR-20a-5p in hDPSCs to clarify the function of miR-20a-5p on osteogenesis both in vitro and vivo. Direct bind sites between miR-20a-5p and BAMBI were confirmed by dual-luciferase reporter assay, and the underlying mechanisms were investigated with cell co-transfections.The expression of miR-20a-5p was showed to be upregulated during osteogenesis of hDPSCs. Inhibition of miR-20a-5p could weaken the intensity of ALP/ARS staining and downregulate the expression of mRNAs and proteins of osteogenic markers, while overexpression of miR-20a-5p could enhance the intensity of ALP/ARS staining and the expression of osteogenic markers. Both micro-CT reconstruction images and histological results showed that miR-20a-5p could promote the regeneration of calvarial defects. miR-20a-5p directly targeted bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI), and the latter one was an inhibitor of hDPSC osteogenesis. Silencing BAMBI partially reversed the suppression effect of miR-20a-5p knockdown on osteogenesis. Phosphorylation of Smad5 and p38 was decreased when miR-20a-5p was silenced, whereas p-Smad5 and p-p38 were upregulated when miR-20a-5p was overexpressed or BAMBI was silenced.It is demonstrated that miR-20a-5p functioned as a regulator of BAMBI to activate the phosphorylation of Smad5 and p38 during osteogenic differentiation of hDPSCs.© 2021. The Author(s).

基金:

基金编号: grant no. 2019M663530 grant no. RD-02-201904

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 2 区 细胞与组织工程 2 区 细胞生物学 2 区 医学:研究与实验
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 细胞与组织工程 2 区 细胞生物学 2 区 医学:研究与实验
JCR分区:
出版当年[2021]版:
Q1 CELL & TISSUE ENGINEERING Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL
最新[2023]版:
Q1 CELL & TISSUE ENGINEERING Q1 CELL BIOLOGY Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]State Key Laboratory of Oral Diseases & National Clinical Research Center forOral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section, South Renmin Road, Chengdu 610041, Sichuan, China [2]Department of Temporomandibular Joint, West China Hospital ofStomatology, Sichuan University, Chengdu, China
通讯作者:
通讯机构: [1]State Key Laboratory of Oral Diseases & National Clinical Research Center forOral Diseases, West China Hospital of Stomatology, Sichuan University, No.14, 3rd Section, South Renmin Road, Chengdu 610041, Sichuan, China [3]Department ofOrthodontics, West China Hospital of Stomatology, Sichuan University,Chengdu, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43389 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号